Clinical Trial Update: LIP-01 in Hypercholesterolemia [Phase 1]

View source ↗

Summary

Phase 1 trial of LIP-01 for hypercholesterolemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• LIP-01

Snippet

Sponsor: Afexa Life Sciences Inc | Conditions: Hypercholesterolemia | Phase 1 | Status: COMPLETED